Oct 22, 2026 07:31AM
Oct 22, 2026 07:30AM
Aug 12, 2026 07:30AM
May 13, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 4, 2024 08:35AM Arbutus Biopharma (ABUS) Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna (MRNA)
Apr 4, 2024 08:30AM
Feb 29, 2024 07:30AM
Jan 8, 2024 07:36AM
Jan 8, 2024 07:30AM
Nov 7, 2023 07:30AM
Nov 7, 2023 07:15AM
Nov 7, 2023 07:15AM Arbutus Announces CEO, William Collier, to Retire December 31, 2023
Oct 11, 2023 08:05AM
Sep 11, 2023 04:15PM
Aug 3, 2023 07:30AM
May 4, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM Arbutus Announces FDA Clinical Hold on IND Application for AB-101, an oral PD-L1 inhibitor
Feb 28, 2022 09:30AM
Nov 4, 2021 07:30AM
Nov 4, 2021 07:30AM
Aug 5, 2021 07:30AM
Aug 5, 2021 07:30AM
Jul 7, 2021 07:00AM
Jul 7, 2021 07:00AM Arbutus Receives Authorization to Proceed with an Investigational New Drug Application (IND) for AB-729, its Proprietary Subcutaneously-Delivered RNAi Agent
Jul 7, 2021 07:00AM
Dec 17, 2020 09:22AM
May 11, 2020 09:28AM
Feb 10, 2020 09:21AM
Aug 5, 2019 07:30AM
Aug 5, 2019 07:30AM
Jul 2, 2019 04:03PM Arbutus Biopharma (ABUS) Sells Part of ONPATTRO Royalty Interest to OMERS
Jul 2, 2019 04:01PM
Jul 2, 2019 04:01PM
May 6, 2019 04:01PM
May 6, 2019 04:01PM
Mar 7, 2019 04:01PM
Mar 7, 2019 04:01PM
Nov 7, 2018 04:01PM Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update
Nov 7, 2018 04:01PM
Aug 13, 2018 08:33AM
Aug 13, 2018 08:30AM
Aug 13, 2018 08:30AM
Aug 2, 2018 04:00PM
Aug 2, 2018 04:00PM
Jul 10, 2018 07:00AM Arbutus Presents Corporate Update on Key Milestones
Jul 10, 2018 07:00AM

335,221 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All